| Outcome Measures: |
Primary: Area under the curve, Before and after intervention with ambulatory continuous glucose monitoring during 72 h, oxidase glucose iPro ™ 2, 56 days|Mean amplitude of glucose excursions (MAGE), Before and after intervention with ambulatory continuous glucose monitoring during 72 h, oxidase glucose iPro ™ 2, 56 days | Secondary: Fasting plasma glucose, Before and after intervention by spectrophotometry, 56 days|Postprandial glucose, Before and after intervention with ambulatory continuous glucose monitoring during 72 h, oxidase glucose iPro ™ 2, 56 days|A1C, Before and after intervention by high-performance liquid chromatography, 56 days|Total cholesterol, Before and after intervention by spectrophotometry, 56 days|Triglycerides, Before and after intervention by spectrophotometry, 56 days|High-density lipoprotein cholesterol, Before and after intervention by spectrophotometry, 56 days|Low-density lipoprotein cholesterol, Friedewald formula, 56 days|Very-low density lipoprotein, Friedewald formula, 56 days|Alanine aminotransferase, Before and after intervention by spectrophotometry, 56 days|Aspartate aminotransferase, Before and after intervention by spectrophotometry, 56 days|Creatinine, Before and after intervention by spectrophotometry, 56 days|Blood pressure, Before and after intervention using a digital manometer, 56 days|Body and visceral fat %, Before and after intervention using a impedance bascule, Tanita MR, 56 days
|
